LONDON (Reuters) - Roche Holding AG, the world's biggest maker of cancer drugs, said it would build on its drive into personalized medicine to hold onto its long-term growth momentum and said it would keep up spending on research and development. In a statement ahead of a presentation to investors in London on Wednesday, the Swiss drugmaker said it expected 19 late stage trials to read out over the next 18 months. ... Click here to read the rest
No comments:
Post a Comment